Related Experiment Videos
Cardiorespiratory decompensation following methylprednisolone administration
K G Lucas1, D L Howrie, C K Phebus
1Department of Pediatrics, Children's Hospital of Pittsburgh.
Pediatric Hematology and Oncology
|July 1, 1993
Summary
A child on chemotherapy experienced severe hypotension and shock after receiving ondansetron and high-dose methylprednisolone. This case highlights potential cardiovascular risks associated with rapid corticosteroid administration in pediatric oncology.
Area of Science:
- Pediatric Oncology
- Cardiovascular Pharmacology
- Clinical Toxicology
Background:
- Primitive neuroectodermal tumors (PNET) are aggressive central nervous system cancers often treated with multidrug chemotherapy.
- Chemotherapy regimens frequently include antiemetics like ondansetron and corticosteroids such as methylprednisolone to manage side effects.
- Cardiovascular adverse events, though rare, can occur during cancer treatment, necessitating careful monitoring.
Observation:
- A 2-year-old female diagnosed with PNET developed acute hypotension, bradycardia, and shock shortly after intravenous administration of ondansetron and high-dose methylprednisolone.
- The patient's clinical course was characterized by severe hemodynamic instability requiring intensive management.
- The event occurred during a standard chemotherapy cycle, suggesting a potential drug-related reaction.
Findings:
- The severe cardiovascular reaction, including hypotension and shock, was temporally associated with the administration of ondansetron and high-dose methylprednisolone.
- While the exact cause remains unclear, an idiosyncratic reaction to the rapid infusion of high-dose adrenal corticosteroids is hypothesized.
- This event underscores the potential for serious adverse drug reactions in pediatric patients undergoing intensive cancer therapy.
Implications:
- Close monitoring of pediatric patients receiving high-dose corticosteroid therapy, particularly during chemotherapy, is crucial for early detection of adverse cardiovascular events.
- Slow administration rates for high-dose corticosteroids like methylprednisolone may mitigate the risk of severe hemodynamic instability.
- Further investigation into the mechanisms underlying idiosyncratic reactions to corticosteroids in this population is warranted to improve patient safety.